Epidemiological research on radiation-induced cancer in atomic bomb survivors

Radiation Effects Research Foundation (RERF). A Brief Description. Hiroshima: RERF, 2014. http://www.rerf.jp/shared/briefdescript/briefdescript_e.pdf (6 August 2015, date last accessed)

Young RW , Egbert SD , Cullings HM et al . Survivor Dosimetry, Part B, DS02 Free-in-Air Neutron and Gamma Tissue Kerma Relative to DS86. In: Young RW , Kerr GD (ed). Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki – Dosimetry System 2002–DS02. Hiroshima: Radiation Effects Research Foundation, 2005, 848–57. http://www.rerf.jp/shared/ds02/index2.html (6 August 2015, date last accessed)

10.1667/RR3546.1

Okajima S , Fujita S . Radiation dose from residual radioactivity. In: Roesch WC (ed). US–Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki (DS86). Hiroshima: Radiation Effects Research Foundation, 1987, 205–26. http://www.rerf.jp/cgi-bin/frame.cgi?home=ds86a&page=Chapter6 (6 August 2015, date last accessed)

10.1667/RR13822.1

10.1667/RR1801.1

10.1667/RR2892.1

10.1200/JCO.2010.31.3080

10.1667/RR2629.1

10.1667/RR0763.1

10.1667/RR2083.1

10.1667/RR2819.1

10.1667/RR2841.1

10.1007/s10552-012-0086-8

10.1667/RR13494.1

Samartzis, 2011, Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki, J Bone Joint Surg, 93, 1, 10.2106/JBJS.J.00256

10.2106/JBJS.L.00546

10.1002/ijc.27749

10.1016/S0140-6736(00)02506-X

10.1093/jnci/djn045

10.1038/sj.bjc.6601322

10.1002/ijc.11400

10.1016/S1470-2045(15)00209-0

10.1158/0008-5472.CAN-10-0276

10.1126/science.1260825

10.1002/mc.20277

10.1158/0008-5472.CAN-08-0293

10.1667/RR3183.1